IBTA vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

IBTA

34.4
AI Score
VS
PACS Wins

PACS

36.6
AI Score

Investment Advisor Scores

IBTA

34score
Recommendation
EXTENDED

PACS

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IBTA PACS Winner
Forward P/E 24.6914 17.6367 PACS
PEG Ratio 0 1.1766 Tie
Revenue Growth 17.5% 9.1% IBTA
Earnings Growth -90.2% 51.6% PACS
Tradestie Score 34.4/100 36.6/100 PACS
Profit Margin -4.5% 4.9% PACS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY IBTA

Relative Price Performance (Last 90 Days)

IBTA 1M: +38.5% · 3M: +57.0% PACS 1M: +12.8% · 3M: +11.3%

Current Technical Phase

IBTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.7% over 20 days), RSI 71

RSI (14): 71.2 · Price: $59.94

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 60

RSI (14): 60.5 · Price: $50.06

Fundamentals Snapshot

Metric IBTA PACS
Market Cap — —
Forward P/E 28.0 17.6
Trailing P/E — 27.7
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.8% 0.2%
Operating Margin 0.0% 0.1%
EPS -0.67 1.77
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.